See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Presenter: Andreas Baumbach

October 29, 2013

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Presenter: John Puskas

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Presentation TCT 2013

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

Presenter: Marc Penn

October 29, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Presentation TCT 2013

When, Why, and How to Cardiovert

Presenter: Mintu Turakhia

October 29, 2013

Presentation TCT 2013

Mitral Valve-in-Ring

Presenter: Vinayak Bapat

October 29, 2013

Presentation TCT 2013

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

How Did I Treat This Case?(3)

Presenter: Eric Van Belle

October 29, 2013

Advertisement

Slides

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

When, Why, and How to Cardiovert

Mitral Valve-in-Ring

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

How Did I Treat This Case?(3)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content